Deficit accumulation frailty index (DAFI) and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance).
      Google Scholar   
Citation:
Blood Adv
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3733  
Children:
None
Program:
CCP
Primary Committee:
Older Adult
Sec. Committees:
   
Pharmas:
Bayer Healthcare/Berlex (11001)  
Grants:
UG1CA189823, UG1CA189824;UG1CA23975;.R01AG068193, R56AG068086, R01CA129769, R35CA197289, R35CA283926, R01CA127617  
Corr. Author:
 
Authors:
                   
Networks:
CAPITAL, LAPS-MN026, LAPS-MO011, NC002, NY018, PA075   
Study
Alliance-A152124
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-11001, CALGB-11002, CALGB-361006, CALGB-361101
Phases:
N/A, 2, N/A
Keywords: